Clinical Trial Update: Meal Replacement Study [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating a meal replacement program for obesity has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Obesity | Phase 3 | Status: WITHDRAWN